Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature.

@article{Francolini2018StereotacticBR,
  title={Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature.},
  author={Giulio Francolini and Beatrice Detti and Gianluca Ingrosso and Isacco Desideri and Carlotta Becherini and G Carta and Donato Pezzulla and G. Caramia and Luca Dominici and Virginia Maragna and M. A. Teriaca and Marta Bottero and Lorenzo Livi},
  journal={Critical reviews in oncology/hematology},
  year={2018},
  volume={131},
  pages={
          24-29
        }
}
  • Giulio Francolini, Beatrice Detti, +10 authors Lorenzo Livi
  • Published in
    Critical reviews in oncology…
    2018
  • Medicine
  • BACKGROUND Stereotactic body radiotherapy (SBRT) is characterized by the delivery of high doses of ionizing radiation in few fractions. It is highly effective in achieving local control, and, due to the high biological effective dose administered, it seems to overcome the radioresistance of renal cell carcinoma (RCC). Thus, SBRT could constitute a treatment option for the management of localized RCC in patients who are not surgical candidates. In this paper, we report an overview about data… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.

    Treatment selection in metastatic renal cell carcinoma : Towards an individualised approach

    VIEW 4 EXCERPTS
    CITES BACKGROUND & RESULTS
    HIGHLY INFLUENCED